Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action

Type 2 diabetes is a syndrome characterized by relative insulin deficiency, insulin resistance and increased hepatic glucose output. Medications used to treat the disease are designed to correct one or more of these metabolic abnormalities. Current recommendations of the American Diabetes Associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzati, Bartolomeo, Zucco, Chiara, Miglietta, Sara, Lamberti, Federico, Bruno, Graziella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034109/
https://www.ncbi.nlm.nih.gov/pubmed/27713388
http://dx.doi.org/10.3390/ph3093005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034109/
https://www.ncbi.nlm.nih.gov/pubmed/27713388
http://dx.doi.org/10.3390/ph3093005

Ejemplares similares